Hostname: page-component-7b7567c8c-w7t8q Total loading time: 0 Render date: 2026-11-18T07:38:51.222Z Has data issue: false hasContentIssue false

Medical Pharmaceuticals and Distributive Justice

Published online by Cambridge University Press:  18 December 2007

MICHAEL BOYLAN
Affiliation:
Department of Philosophy, Marymount University, Arlington, Virginia
Rights & Permissions [Opens in a new window]

Extract

There are deep structural conflicts between the mission of healthcare as cooperative care to the sick and injured and that of healthcare as a business whose mission is maximizing profits. These conflicts come to the fore in the medical pharmaceutical industry. I first set these out in a context that addresses the mission of healthcare, then examine the relative roles of competitive and cooperative systems of distributive justice, and then argue for the creation of nonprofit pharmaceutical companies and the transformation of many for-profit companies into companies subject to public oversight and profit curbs. The recommendations are aspirational for the United States (because it does not yet offer universal health coverage) but it is meant to be action guiding for those industrialized countries wealthy enough to provide universal health coverage.

Information

Type
SPECIAL SECTION: OPEN FORUM
Copyright
© 2008 Cambridge University Press